National Centre for Antimicrobial Stewardship
@ncas.bsky.social
We are a One Health digital and health services research centre of excellence based in Melbourne Australia. Director Prof Karin Thursky. Posts by the team!
Our modus operandi for our programs - the Learning Health System.
ASHE Journal@ashejournal.bsky.social · 9mo agoRead on in this letter to the editor--Applying the Learning Health System framework to overcome barriers in antimicrobial decision support: lessons from the Guidance redesign doi.org/10.1017/ash....
Read on in this letter to the editor--Applying the Learning Health System framework to overcome barriers in antimicrobial decision support: lessons from the Guidance redesign doi.org/10.1017/ash....
Applying the Learning Health System framework to overcome barriers in antimicrobial decision support: lessons from the Guidance redesign | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core
Applying the Learning Health System framework to overcome barriers in antimicrobial decision support: lessons from the Guidance redesign - Volume 5 Issue 1
doi.org
Fever's going up up up... 🎶 Remember to take cultures before starting antibiotics. Stay tuned for more NCAS Halloween posters over the coming weeks. @NCASHalloween2025 #antimicrobialoween
www.linkedin.com/posts/fltltm...
An interesting shift in the expected skills profile. While AI and… | Flt.Lt. Sridhar Chakravarthi Mulakaluri© | 101 comments
An interesting shift in the expected skills profile. While AI and analytical skills becoming core skills is an obvious one, the more interesting quadrants are emerging skills and Out-of-focus skills. ...
linkedin.com
New Frontiers in Antimicrobial Stewardship @escmid.bsky.social Keynote lecture: Karin Thursky @ncas.bsky.social How can we reframe + conceptualize #AMS to work for 2025 + beyond. Who outside of healthcare really know the ins and outs of what #AMR #AMS mean? #ESCMIDGlobal #ESCMID2025
Appreciate the shoutout by Prof Thursky on the key role played by #pharmacists in #antimicrobialstewardship and the importance of prescriber providing indication to facilitate appropriateness assessment. @ncas.bsky.social #ESCMIDGlobal
#AI is here + will become key in #antimicrobialstewardship #AMS Flagged by Prof Thursky @ncas.bsky.social at #ESCMID2025 #ESCMIDGlobal - this paper is a great blueprint for implementing AI in AMS programmes Link: www.thelancet.com/journals/lan...
Glad to hear how #Epic EMR data are being handled to support #antimicrobialstewardship @ncas.bsky.social #ESCMIDGlobal
Importance of combining appropriateness and consumption to form a more complete picture of antimicrobial use at a local hospital and national level. @cazchen.bsky.social presenting a comparative analysis of 192 hospitals across two national programs. @ausantibiotics.bsky.social #ASA2025
What a way to wrap up Day 1 of #ASA2025 with our Director Prof Kas Thursky delivering the prestigious Howard Florey Oration. We’re so proud to be a part of her visionary work pioneering #AMS in Australia and internationally and driving the field forward. @ausantibiotics.bsky.social
A huge amount of careful thought, validation work and technical gymnastics that went into the development of real time AMS reports for AMS teams. Ms Jenna Maleki presenting on the development of dashboard reports in the Guidance application. @ausantibiotics.bsky.social #ASA2025
Pharmacist Josephine Wen discussing the value of concise targeted auditing tools in conjunction with larger point prevalence audits for AMS programs. @ausantibiotics.bsky.social #ASA2025
A national audit of 200 hospitals showed ongoing poor prescribing in surgical prophylaxis, in particular with extended durations of post-operative prophylaxis. Dr Courtney Ierano presenting the 2023 results of our Surgical NAPS program @ausantibiotics.bsky.social #AMSsky #ASA2025
We shouod not forget about the effectiveness of foundational AMS activities. Restriction and pre approval can be very effective (especially if combined with post prescription review) www.sciencedirect.com/science/arti...
Fluoroquinolone consumption and resistance after an Antibiotic Stewardship Team intervention—an interventional study in a single hospital in southern Poland from 2018–2023.
Among the many classes of antibiotics, fluoroquinolones (FQ) are widely used in empiric treatment. Unfortunately, resistance to FQ is progressively ri…
sciencedirect.com
Please read this thread and support the prioritisation of #AMR/#AMS grand funding.
Anita Williams@catanita.bsky.social · 2y agoThe #NHMRC & MRFF are developing a National Health and Medical Research Strategy to provide national direction, build on Australia’s strengths in the health and medical research sector, fill any gaps, and continue to attract researchers and investors to #Australia 1/ #academicsky #medsky #IDsky #AMR
Exciting News! 🌟 Come and join us in lovely Vienna for the 3rd Behavioral Insights & Antimicrobial Resistance Workshop 📅 15–16 May 2025 📍University of Vienna (and online) 👉 Register by March 31st: www.a-bc.network/active.html
ABC Network: Activities
a-bc.network
Miroslav Sirota@miroslavsirota.bsky.social · 2y ago1/2 Join us to explore how behavioural science can help address antimicrobial resistance. 3rd Behavioural Insights & Antimicrobial Resistance Workshop When: 15–16 May 2025 Where: University of Vienna (+online option) Organised by @robertboehm.bsky.social and @miroslavsirota.bsky.social
A starter pack for people interested in behavioral, cognitive and cultural aspects of antimicrobial resistance. Happy to add you if you are active in this area. go.bsky.app/9i8zPz See also www.a-bc.network #AMR #AntibioticResistance #AntibioticStewardship #BehavioralInsights #AMRBehaviorChange
Great thread about the real world experience of procalcitonin to guide IV antis in children. Low compliance with the algorithm, with a test that also disrupted routine workflow. Diagnostic stewardship requires careful implementation design.
Prof Enitan Carrol@carrolenitan.bsky.social · 2y ago2/ The BATCH trial was a pragmatic, multicentre, open-label, individually randomised, controlled trial conducted in 15 hospitals in England and Wales between June 2018, and Oct 2022.
Chlorhexidine or hydrophobic PICCs were not superior to standard polyurethane PICCs for the prevention of device failure due to infectious or noninfectious complications. Read the full PICNIC trial results: nej.md/3Pqk25M #MedSky
I don't want a lot for Christmas... 🎵 www.ncas-australia.org/ClinicalFact... #antimicrobialmas #AMSsky
www.bmj.com/content/387/... Have not heard about this before, but very interesting read. Maybe it’s time that drug companies lose any control over clinical trials to obtain approval.
Doubts over landmark heart drug trial: ticagrelor PLATO study
A top selling antiplatelet drug has never quite shaken off doubts about its advantage over cheaper rivals. With generic versions of ticagrelor about to launch, Peter Doshi takes a fresh look at the ev...
bmj.com
It's beginning to look a lot like #antimicrobialmas... The first in our 2024 NCAS Christmas poster series - stay tuned for the remaining posters to be released over the coming weeks. #AMSsky
